Pharmaceutical companies by P/E ratio

Share price divided by the last twelve months' earnings per share: how many years of today's profit the price pays for. A company making a loss has none.

Edgewise Therapeutics has the lowest figure of the 33 pharmaceutical companies ranked by P/E ratio, at 4.9, followed by Alnylam Pharmaceuticals (7.7) and Novo Nordisk (10.0). Figures as of 18 Nov 2026, 16:47 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
33
Lowest
Edgewise Therapeutics4.9
Median
40.3
Combined market value
NZ$9.27T
Countries
10
Not ranked
28no P/E ratio on file

Market values as of .

All countries
All sectors
Pharmaceuticals
NZD
Clear filters
Pharmaceutical companies by P/E ratio
#CompanyP/E ↑Market capPriceToday1 yearPrice, 30 daysCountry
1Edgewise TherapeuticsEWTX · Health Care4.9NZ$8.2BNZ$75.07 2.00% down 88% up United States
2Alnylam PharmaceuticalsALNY · Health Care7.7NZ$37BNZ$276.24 3.12% down 66% down United States
3Novo NordiskNVO · Health Care10.0NZ$317.5BNZ$72.04 2.85% down 17% down Denmark
4GrifolsGRFS · Health Care10.3NZ$10.6BNZ$15.51 1.33% down 1% up Spain
5Bristol-Myers SquibbBMY · Health Care13.4NZ$224.2BNZ$109.70 1.86% down 34% up United States
6ZoetisZTS · Health Care14.3NZ$62.2BNZ$152.98 0.58% up 29% down United States
7GSKGSK · Health Care17.0NZ$178.2BNZ$88.90 0.91% down 6% up United Kingdom
8Ascendis PharmaASND · Health Care17.8NZ$32.4BNZ$493.89 0.04% down 28% up Denmark
9Regeneron PharmaceuticalsREGN · Health Care21.1NZ$180.3BNZ$1,742.48 0.15% down 36% up United States
10United TherapeuticsUTHR · Health Care21.8NZ$44.9BNZ$1,054.26 0.94% down 23% up United States
11SanofiSNY · Health Care23.5NZ$207BNZ$86.21 0.45% down 4% down France
12AstraZenecaAZN · Health Care25.4NZ$506.7BNZ$326.68 1.63% down 2% up United Kingdom
13Protagonist TherapeuticsPTGX · Health Care26.5NZ$14.9BNZ$228.50 0.59% up 46% up United States
14NovartisNVS · Health Care29.8NZ$536.5BNZ$284.09 2.02% down 25% up Switzerland
15Vertex PharmaceuticalsVRTX · Health Care34.4NZ$247.3BNZ$975.26 0.20% up 27% up United States
16Abbott LaboratoriesABT · Health Care39.2NZ$331.1BNZ$191.20 0.22% up 17% down United States
17PfizerPFE · Health Care40.3NZ$292.7BNZ$51.35 1.00% down 14% up United States
18Dr. Reddy's LaboratoriesRDY · Health Care41.6NZ$22.8BNZ$27.30 1.32% up 5% up India
19Johnson & JohnsonJNJ · Health Care41.8NZ$1.21TNZ$502.43 1.05% down 38% up United States
20GenmabGMAB · Health Care43.8NZ$57.5BNZ$93.29 1.46% down 70% up Denmark
21Eli LillyLLY · Health Care45.0NZ$2.25TNZ$2,526.43 2.04% down 35% up United States
22Royalty PharmaRPRX · Health Care45.0NZ$72.1BNZ$125.46 0.26% up 78% up United States
23AbbVieABBV · Health Care49.7NZ$931.2BNZ$526.81 1.26% down 26% up United States
24Corcept TherapeuticsCORT · Health Care51.2NZ$13.6BNZ$123.99 2.88% down 8% down United States
25BeOne MedicinesONC · Health Care51.7NZ$83.9BNZ$734.38 2.47% down 17% up Switzerland
26Amneal PharmaceuticalsAMRX · Health Care53.9NZ$13.7BNZ$39.27 2.06% up 83% up United States
27Jazz PharmaceuticalsJAZZ · Health Care72.2NZ$28.6BNZ$444.80 1.42% up 37% up Ireland
28Kiniksa Pharmaceuticals InternationalKNSA · Health Care72.7NZ$13.7BNZ$174.88 0.92% up 126% up United Kingdom
29TG TherapeuticsTGTX · Health Care97.4NZ$18BNZ$118.94 4.10% up 107% up United States
30Teva Pharmaceutical IndustriesTEVA · Health Care98.3NZ$89.8BNZ$77.00 0.84% down 74% up Israel
31Ligand PharmaceuticalsLGND · Health Care121NZ$10.9BNZ$546.87 2.16% up 43% up United States
32Merck & CoMRK · Health Care141NZ$627.2BNZ$254.42 2.60% down 51% up United States
33Takeda PharmaceuticalTAK · Health Care305NZ$124.4BNZ$38.95 1.22% down 54% up Japan

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 1.8220 NZD). 28 companies have no P/E ratio on file and are not ranked here.

Questions and answers

Which pharmaceutical companies have the lowest P/E ratio?

Edgewise Therapeutics (4.9), Alnylam Pharmaceuticals (7.7) and Novo Nordisk (10.0) have the lowest P/E ratio of the 33 pharmaceutical companies ranked here as of 18 Nov 2026, 16:47 UTC.

How many pharmaceutical companies are in this ranking?

33 are ranked by P/E ratio. 28 more have no P/E ratio on file and are left out rather than ranked at zero.

What are these pharmaceutical companies worth together?

The 33 pharmaceutical companies ranked by P/E ratio have a combined market value of NZ$9.27T as of 18 Nov 2026, 16:47 UTC.

What does ranking by P/E ratio measure?

Share price divided by the last twelve months' earnings per share: how many years of today's profit the price pays for. A company making a loss has none.

Cite this page

Funkfolio, “Pharmaceutical companies by P/E ratio”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=pe-ratio

Underlying data: Yahoo Finance; SEC EDGAR.